SignalEU/UK
Roche Holding AG (RHHBY) Q3 2026 Sales/Trading Call Transcript
High-priority alert based on source significance and keyword relevance.
Context
What happened: Roche held its Q3 2026 sales webinar, with CEO Thomas Schinecker and CFO Alan Hippe presenting results and taking questions from analysts.
Key numbers: Group sales up 6% year-to-date; Pharma up 7%; Q3 group growth of 7% in CER.
Why it matters: Schinecker described the quarter as strong performance with significant portfolio progress, and noted currency has now stabilized.
What changed
Roche held its Q3 2026 sales webinar, with CEO Thomas Schinecker and CFO Alan Hippe presenting results and taking questions from analysts.
Why it matters
Schinecker described the quarter as strong performance with significant portfolio progress, and noted currency has now stabilized.